Home|Journals|Articles by Year Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

Original Article



Protective and curative effects of Livolin forte® on carbon tetrachloride-induced liver damage in Wistar rats

Olaoluwa S. Olukiran, Rufus O. Akomolafe, Kayode D. Bamitale, Akande O. Ajayi, Raphael E. Okonji, Ronald A. Bejide.

Cited by (1)

Abstract
Objective: Livolin forte® (LIV) is a hepatoprotective drug that is being used in hospitals worldwide in the treatment and management of liver diseases. However, as it appear through the available published literature, the physiological effects of the drug on the liver using a rat model of hepatotoxicity is not yet well established. This study assessed the curative and prophylactic effects of LIV on carbon tetrachloride (CCl4) induced liver damage in rats.
Methods: Twenty-four adult Wistar rats were randomly divided into four groups: group I (normal control) received 0.3 ml/kg/day of propylene glycol for one month; group II (toxicant control) was given 0.7 ml/kg/day of CCl4 dissolved in olive oil (1:1, v/v) orally for 7 days; group III received 5.2 mg/kg/day of LIV for one month followed by CCl4 for one week; group IV received CCl4 for one week and subsequently LIV (5.2 mg/kg/day) was administered for one month. Half of the rats were sacrificed one day after the last treatment, the other half after a 2-week recovery period.
Results: The toxicant control group had significantly higher AST and ALT activities, total bilirubin and lower total protein and GSH levels compared to the normal control rats. Similarly, significant increase in serum activities of AST and ALT were observed in group III compared to the normal control rats a day after the last treatment with CCl4, whereas after the recovery period no significant differences were observed in nearly all the parameters. Moreover, group IV showed no significant differences in the parameters mentioned above compared to the normal control rats a day after the last treatment with LIV and after the recovery period.
Conclusion: The results of this study indicated that LIV was better as a curative agent rather than a prophylactic agent in rats.

Key words: Carbon tetrachloride; Curative; Livolin forte®; Prophylactic; Rat



Full-text options

Full-text Article



Readers of this article also read the following articles
»A prevalence study of lower urinary tract symptoms (LUTS) in males
»Assessing the opinions of subjects with or without sustained hand injury about toe-to-thumb transfer
»Traumatic diaphragmatic hernia presenting with intestinal obstruction: case report
»Role of oxidative stress in opiate withdrawal and dependence: Exploring the potential use of honey.
»Phoenix dactylifera linn as a potential novel anti-oxidant in treating major opioid toxicity.
»Knowledge of nurses about breast cancer risk factors, general awareness and screening procedures in South India
»Prevalence and Susceptibility Pattern of Methicillin Resistant Staphylococcus aureus (MRSA)
»Analysis of Comorbidity of the Patients Affected by Staphylococcal Bacteremia/Sepsis in the Last Ten Years
»Genome-wide Identification and Expression Analysis along the Leaf developmental Gradient of the Sigma Factor Gene Family in Foxtail Millet (Setaria italica)
»Complications and short to midterm results in a case series of 52 CUE procedures using a modified caudo-medial approach
»Modified small incision technique of basilic vein transposition as a means of angioaccess for long-term dialysis: a preliminary report



Advertisement
American Journal of Research in Medical Sciences

SUBMIT YOUR ARTICLE NOW




ScopeMed.com
BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.